| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc. | President and CEO, Director | Stock Option (right to buy) | 132,003 | 12 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ERNA | Eterna Therapeutics Inc. | 12 Jan 2023 | 1 | $0 | 4 | President and CEO, Director | 13 Jan 2023, 18:30 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 01 Aug 2022 | 1 | $0 | 4 | Interim President and CEO, Director | 03 Aug 2022, 20:01 |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | 26 May 2022 | 0 | $0 | 3 | Interim President and CEO | 01 Jun 2022, 17:00 |